News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
313,928 Results
Type
Article (11254)
Company Profile (64)
Press Release (302608)
Multimedia
Podcasts (13)
Webinars (5)
Section
Business (100007)
Career Advice (690)
Deals (17871)
Drug Delivery (17)
Drug Development (31007)
Employer Resources (40)
FDA (6784)
Job Trends (6398)
News (156316)
Policy (11123)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (828)
Accelerated approval (23)
Adcomms (5)
Allergies (136)
Alliances (20804)
ALS (89)
Alzheimer's disease (633)
Antibody-drug conjugate (ADC) (149)
Approvals (7160)
Artificial intelligence (277)
Autoimmune disease (107)
Automation (24)
Bankruptcy (115)
Best Places to Work (5222)
BIOSECURE Act (2)
Biosimilars (79)
Biotechnology (58)
Bladder cancer (95)
Brain cancer (28)
Breast cancer (327)
Cancer (2365)
Cardiovascular disease (147)
Career advice (597)
Career pathing (13)
CAR-T (115)
CDC (6)
Cell therapy (307)
Cervical cancer (13)
Clinical research (27500)
Collaboration (859)
Compensation (511)
Complete response letters (20)
COVID-19 (843)
CRISPR (34)
C-suite (588)
Cystic fibrosis (60)
Data (3368)
Denatured (4)
Depression (50)
Dermatology (34)
Diabetes (173)
Diagnostics (3126)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (18)
Drug discovery (167)
Drug pricing (27)
Drug shortages (6)
Duchenne muscular dystrophy (95)
Earnings (47672)
Editorial (10)
Employer branding (6)
Employer resources (42)
Events (51076)
Executive appointments (630)
FDA (8362)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (21)
Funding (705)
Gene editing (66)
Generative AI (26)
Gene therapy (202)
GLP-1 (274)
Government (1043)
Grass and pollen (4)
Guidances (240)
Healthcare (6940)
HIV (32)
Huntington's disease (19)
IgA nephropathy (46)
Immunology and inflammation (88)
Immuno-oncology (29)
Indications (88)
Infectious disease (942)
Inflammatory bowel disease (87)
Inflation Reduction Act (3)
Influenza (39)
Intellectual property (65)
Interviews (86)
IPO (9068)
IRA (6)
Job creations (1405)
Job search strategy (536)
JPM (11)
Kidney cancer (14)
Labor market (19)
Layoffs (146)
Leadership (9)
Legal (2935)
Liver cancer (35)
Longevity (15)
Lung cancer (269)
Lymphoma (200)
Machine learning (29)
Management (14)
Manufacturing (281)
MASH (68)
Medical device (4717)
Medtech (4738)
Mergers & acquisitions (9437)
Metabolic disorders (439)
mRNA (43)
Multiple sclerosis (75)
NASH (8)
Neurodegenerative disease (161)
Neuropsychiatric disorders (25)
Neuroscience (1249)
NextGen: Class of 2026 (2237)
Non-profit (1192)
Now hiring (19)
Obesity (189)
Opinion (73)
Ovarian cancer (86)
Pain (69)
Pancreatic cancer (98)
Parkinson's disease (158)
Partnered (16)
Patents (113)
Patient recruitment (214)
Peanut (61)
People (32650)
Pharmaceutical (14)
Pharmacy benefit managers (5)
Phase 1 (7933)
Phase 2 (11378)
Phase 3 (10130)
Pipeline (4024)
Policy (48)
Postmarket research (1174)
Preclinical (3410)
Press Release (69)
Prostate cancer (128)
Psychedelics (13)
Radiopharmaceuticals (158)
Rare diseases (399)
Real estate (2348)
Recruiting (10)
Regulatory (9038)
Reports (22)
Research institute (858)
Resumes & cover letters (91)
Rett syndrome (29)
RNA editing (8)
RSV (17)
Schizophrenia (86)
Series A (125)
Series B (93)
Service/supplier (2)
Sickle cell disease (42)
Special edition (2)
Spinal muscular atrophy (69)
Sponsored (11)
Startups (1537)
State (1)
Stomach cancer (3)
Supply chain (35)
Tariffs (11)
The Weekly (9)
Vaccines (276)
Venture capital (29)
Weight loss (91)
Women's health (27)
Worklife (4)
Date
Today (45)
Last 7 days (277)
Last 30 days (1162)
Last 365 days (13904)
2026 (4560)
2025 (13836)
2024 (16336)
2023 (19053)
2022 (25523)
2021 (27302)
2020 (24466)
2019 (18269)
2018 (13841)
2017 (13862)
2016 (12854)
2015 (16263)
2014 (12488)
2013 (9951)
2012 (10657)
2011 (11230)
2010 (10678)
Location
Africa (278)
Alabama (42)
Alaska (3)
Arizona (114)
Arkansas (2)
Asia (15984)
Australia (2343)
California (6112)
Canada (2138)
China (364)
Colorado (205)
Connecticut (246)
Delaware (181)
Europe (36352)
Florida (784)
Georgia (134)
Hawaii (3)
Idaho (28)
Illinois (335)
India (46)
Indiana (268)
Iowa (11)
Japan (294)
Kansas (47)
Kentucky (25)
Louisiana (16)
Maine (58)
Maryland (571)
Massachusetts (4629)
Michigan (167)
Minnesota (276)
Mississippi (2)
Missouri (58)
Montana (22)
Nebraska (17)
Nevada (69)
New Hampshire (29)
New Jersey (2008)
New Mexico (11)
New York (1463)
North Carolina (739)
North Dakota (6)
Northern California (3117)
Ohio (177)
Oklahoma (12)
Oregon (17)
Pennsylvania (1011)
Puerto Rico (9)
Rhode Island (24)
South America (416)
South Carolina (22)
Southern California (2403)
Tennessee (96)
Texas (847)
United States (20979)
Utah (178)
Virginia (128)
Washington D.C. (29)
Washington State (479)
West Virginia (3)
Wisconsin (90)
Wyoming (2)
313,928 Results for "reaction biology corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
April 15, 2026
·
9 min read
Press Releases
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
April 8, 2026
·
9 min read
Press Releases
Resverlogix Corp. Announces Issuance of MCTO by ASC
April 2, 2026
·
4 min read
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
·
2 min read
Press Releases
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 21, 2026
·
5 min read
Press Releases
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
April 17, 2026
·
1 min read
Press Releases
Science Corp. Appoints Murat Günel, MD, as Medical Director for Brain-Computer Interfaces
March 31, 2026
·
3 min read
Press Releases
Resverlogix Corp. Provides Bi-Weekly MCTO Status Update
April 1, 2026
·
4 min read
Press Releases
Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates
April 22, 2026
·
5 min read
Press Releases
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 20, 2026
·
7 min read
1 of 31,393
Next
